Is your SMSF actually earning its keep? Here’s how you can tell
Running your own super fund comes with more than paperwork. It comes with a report card, and it's time to see how your numbers stack up.
Expert buy, hold and sell recommendations from our team of analysts.
Running your own super fund comes with more than paperwork. It comes with a report card, and it's time to see how your numbers stack up.
Here are six actions to take to get the most out of the superannuation system before the end of this financial year, which is coming soon!
For traders and active investors with a short-term investment horizon, here are two ideas to consider in these sectors if the Iran attacks prove more difficult than the US expected.
For traders and active investors with a short-term investment horizon, here are two ideas to consider in these sectors if the Iran attacks prove more difficult than the US expected.
Resource-focused Listed Investment Companies shine amid the gloom. Here are three of them.
What’s the “dot plot” from the US Federal Reserve and why is it important? If I trigger the ‘bring forward’ rule by making a non-concessional contribution of $140,000, how much more can I put into super? Are the major brokers bullish on BHP and what’s their target price? Did Macquarie slash its target price for CSL?
After their big sell-off, are the rare earth miners now in the “buy zone”? When is the Annual Return for an SMSF due for lodgement to the ATO? Are the major brokers bullish on Cochlear? Is there still time to get out of the Westpac Dividend Re-Investment Plan?
I’ve covered AFIC and Argo Investments previously in this column but here are two other discounted Listed Investment Companies (LICs) worth a long-term look.
Peter Switzer is joined three expert guests to unpack the biggest stories shaping markets, property and innovation this week.
Each Saturday, we publish a list of the 20 most shorted stocks. Short sellers are bearish on uranium and remain concerned about lithium. Let’s take a look at these two plays, along with medtech/pharma and data centres.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.